SAR of Bromodomain Inhibitor/Linker for Modulation of Release Profile of BET-BRUSH Prodrugs

Exclusively Licensed

The present disclosure provides, in some aspects, macromonomers of Formula (I), and salts thereof; methods of preparing the macromonomers, and salts thereof; Brush prodrugs (polymers); methods of preparing the Brush prodrugs; compounds of Formula (II); conjugates of Formula (III), and salts thereof; pharmaceutical compositions comprising a Brush prodrug, or a conjugate or a salt thereof; kits comprising: a macromonomer or a salt thereof, a Brush prodrug, a compound, a conjugate or a salt thereof, or a pharmaceutical composition; methods of using the Brush prodrugs, or conjugates or salts thereof; and uses of the Brush prodrugs, and conjugates or salts thereof. These chemical entities may be useful in delivering pharmaceutical agents to a subject or cell.

Researchers

Jeremiah A. Johnson / Farrukh Vohidov

Departments: Department of Chemistry
Technology Areas: Therapeutics: Small Molecules
Impact Areas: Healthy Living

  • brush prodrugs and uses thereof
    Canada | Published application
  • brush prodrugs and uses thereof
    European Patent Convention | Published application
  • brush prodrugs and uses thereof
    United States of America | Published application

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.